David Willman is an investigative reporter for the Los Angeles Times based in Washington, D.C. Willman won the Pulitzer Prize for investigative reporting for articles that prompted the market withdrawal of Rezulin, a widely sold diabetes drug. His subsequent reports, documenting widespread pharmaceutical industry payments to federal researchers, triggered a ban of such compensation at the U.S. National Institutes of Health. His work has also exposed the nation’s unreliable system for countering bioterrorism. He is author of “The Mirage Man,” the groundbreaking account of the anthrax letter attacks. Willman’s national honors include the top award from Investigative Reporters and Editors (twice), the Worth Bingham Prize for Investigative Journalism, the Scripps Howard Foundation’s award for best Washington-based reporting and, with colleagues, the George Polk Award.